Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

l-Proline-based-cyclic dipeptides from Pseudomonas sp. (ABS-36) inhibit pro-inflammatory cytokines and alleviate crystal-induced renal injury in mice.

Begum Ahil S, Hira K, Shaik AB, Pal PP, Kulkarni OP, Araya H, Fujimoto Y.

Int Immunopharmacol. 2019 Aug;73:395-404. doi: 10.1016/j.intimp.2019.05.044. Epub 2019 May 28.

PMID:
31151077
2.

A Case of 3-month-old Neglected Elbow Dislocation Managed by Open Reduction and Cruciate Ligament Reconstruction Using Tendon Graft.

Pundkar GN, Sonar SB, Kulkarni OP.

J Orthop Case Rep. 2017 Jul-Aug;7(4):58-60. doi: 10.13107/jocr.2250-0685.852.

3.

Reprint of "Dual blockade of the pro-inflammatory chemokine CCL2 and the homeostatic chemokine CXCL12 is as effective as high dose cyclophosphamide in murine proliferative lupus nephritis".

Devarapu SK, Kumar Vr S, Rupanagudi KV, Kulkarni OP, Eulberg D, Klussmann S, Anders HJ.

Clin Immunol. 2017 Dec;185:119-127. doi: 10.1016/j.clim.2017.10.011. Epub 2017 Oct 28.

PMID:
29111236
4.

Cellular and Molecular Mechanisms of Autoimmunity and Lupus Nephritis.

Devarapu SK, Lorenz G, Kulkarni OP, Anders HJ, Mulay SR.

Int Rev Cell Mol Biol. 2017;332:43-154. doi: 10.1016/bs.ircmb.2016.12.001. Epub 2017 Feb 4. Review.

PMID:
28526137
5.

Zein Microneedles for Transcutaneous Vaccine Delivery: Fabrication, Characterization, and in Vivo Evaluation Using Ovalbumin as the Model Antigen.

Bhatnagar S, Chawla SR, Kulkarni OP, Venuganti VVK.

ACS Omega. 2017 Apr 30;2(4):1321-1332. doi: 10.1021/acsomega.7b00343. Epub 2017 Apr 6.

6.

Effective melanoma cancer suppression by iontophoretic co-delivery of STAT3 siRNA and imatinib using gold nanoparticles.

Labala S, Jose A, Chawla SR, Khan MS, Bhatnagar S, Kulkarni OP, Venuganti VVK.

Int J Pharm. 2017 Jun 20;525(2):407-417. doi: 10.1016/j.ijpharm.2017.03.087. Epub 2017 Apr 1.

PMID:
28373100
7.

The innate immune system in human systemic lupus erythematosus.

Weidenbusch M, Kulkarni OP, Anders HJ.

Clin Sci (Lond). 2017 Apr 25;131(8):625-634. doi: 10.1042/CS20160415. Review.

PMID:
28351959
8.

The Immune System in Tissue Environments Regaining Homeostasis after Injury: Is "Inflammation" Always Inflammation?

Kulkarni OP, Lichtnekert J, Anders HJ, Mulay SR.

Mediators Inflamm. 2016;2016:2856213. doi: 10.1155/2016/2856213. Epub 2016 Aug 11. Review.

9.

Dual blockade of the pro-inflammatory chemokine CCL2 and the homeostatic chemokine CXCL12 is as effective as high dose cyclophosphamide in murine proliferative lupus nephritis.

Devarapu SK, Kumar Vr S, Rupanagudi KV, Kulkarni OP, Eulberg D, Klussmann S, Anders HJ.

Clin Immunol. 2016 Aug;169:139-147. doi: 10.1016/j.clim.2016.07.003. Epub 2016 Jul 5.

PMID:
27392463
10.

Intestinal Dysbiosis, Barrier Dysfunction, and Bacterial Translocation Account for CKD-Related Systemic Inflammation.

Andersen K, Kesper MS, Marschner JA, Konrad L, Ryu M, Kumar Vr S, Kulkarni OP, Mulay SR, Romoli S, Demleitner J, Schiller P, Dietrich A, Müller S, Gross O, Ruscheweyh HJ, Huson DH, Stecher B, Anders HJ.

J Am Soc Nephrol. 2017 Jan;28(1):76-83. doi: 10.1681/ASN.2015111285. Epub 2016 May 5.

11.

Cytotoxicity of crystals involves RIPK3-MLKL-mediated necroptosis.

Mulay SR, Desai J, Kumar SV, Eberhard JN, Thomasova D, Romoli S, Grigorescu M, Kulkarni OP, Popper B, Vielhauer V, Zuchtriegel G, Reichel C, Bräsen JH, Romagnani P, Bilyy R, Munoz LE, Herrmann M, Liapis H, Krautwald S, Linkermann A, Anders HJ.

Nat Commun. 2016 Jan 28;7:10274. doi: 10.1038/ncomms10274.

12.

Anti-fatigue effect of Amarkand on endurance exercise capacity in rats.

Narkhede AN, Jagtap SD, Nirmal PS, Giramkar SA, Nagarkar BE, Kulkarni OP, Harsulkar AM.

BMC Complement Altern Med. 2016 Jan 22;16:23. doi: 10.1186/s12906-016-0995-2.

13.

Neutrophil Extracellular Trap-Related Extracellular Histones Cause Vascular Necrosis in Severe GN.

Kumar SV, Kulkarni OP, Mulay SR, Darisipudi MN, Romoli S, Thomasova D, Scherbaum CR, Hohenstein B, Hugo C, Müller S, Liapis H, Anders HJ.

J Am Soc Nephrol. 2015 Oct;26(10):2399-413. doi: 10.1681/ASN.2014070673. Epub 2015 Feb 2.

14.

Circulatory adipocytokines and lipid profile variations in type-2 diabetic subjects: desirable side-effects of antidiabetic drugs.

Ghadge AA, Harke SM, Khadke SP, Diwan AG, Pankaj M, Kulkarni OP, Ranjekar PK, Kuvalekar AA.

Diabetes Metab Syndr. 2014 Oct-Dec;8(4):230-2. doi: 10.1016/j.dsx.2014.09.010. Epub 2014 Oct 13.

PMID:
25450822
15.
16.

NLRP3 and ASC suppress lupus-like autoimmunity by driving the immunosuppressive effects of TGF-β receptor signalling.

Lech M, Lorenz G, Kulkarni OP, Grosser MO, Stigrot N, Darisipudi MN, Günthner R, Wintergerst MW, Anz D, Susanti HE, Anders HJ.

Ann Rheum Dis. 2015 Dec;74(12):2224-35. doi: 10.1136/annrheumdis-2014-205496. Epub 2014 Aug 18.

PMID:
25135254
17.

Toll-like receptor 4-induced IL-22 accelerates kidney regeneration.

Kulkarni OP, Hartter I, Mulay SR, Hagemann J, Darisipudi MN, Kumar Vr S, Romoli S, Thomasova D, Ryu M, Kobold S, Anders HJ.

J Am Soc Nephrol. 2014 May;25(5):978-89. doi: 10.1681/ASN.2013050528. Epub 2014 Jan 23.

18.

Cathepsin S inhibition suppresses systemic lupus erythematosus and lupus nephritis because cathepsin S is essential for MHC class II-mediated CD4 T cell and B cell priming.

Rupanagudi KV, Kulkarni OP, Lichtnekert J, Darisipudi MN, Mulay SR, Schott B, Gruner S, Haap W, Hartmann G, Anders HJ.

Ann Rheum Dis. 2015 Feb;74(2):452-63. doi: 10.1136/annrheumdis-2013-203717. Epub 2013 Dec 3.

PMID:
24300027
19.

Podocyte loss involves MDM2-driven mitotic catastrophe.

Mulay SR, Thomasova D, Ryu M, Kulkarni OP, Migliorini A, Bruns H, Gröbmayr R, Lazzeri E, Lasagni L, Liapis H, Romagnani P, Anders HJ.

J Pathol. 2013 Jul;230(3):322-35. doi: 10.1002/path.4193.

PMID:
23749457
20.

Re:imagine: a report on the UHC Annual Conference 2012.

White C, Groenewold JJ, Lofgren RP, Meurer SJ, Johnson S, Rogers M, Campbell C, Barbour H, Brazile D, Ondrasik J, Tesmer A, DeBehnke D, Kulkarni OP, van der Geest K, Hart K, Hubenette A, Mass S, Samuels B, Murray J, Carr L, Smith J, Sweeney B, Johnston ML, Angeles PD, Meaney N, Best A, Adams-Campbell H, Hepburn-Smith M, Swarthout MD, Efird L, Nesbit TW, Cawley PJ, Sachs BL, Rees CE, Berman B, Halperin J, Amalfitano C, Anghel S, Luka N, Maund C, Postighone R, Ruggiero C, Belisle C, Stashek C, Dellit TH, Schreuder AB, Leverentz DM, Simon M, Mohan H, Graff AE, Radford MJ, Rivera ML, Bennan J, Hoiting T, Hayes BD, Feemster AA, Benedetti TJ, Walker S, Truwit JD, Enfield KB, Li J, William BJ, Grover-Patrick T, Kay NK, Young JS, Adrian B, Ringel SP, Cole B, Scanlon K, Schwarz R, Pontieri-Lewis V, Ryan J, Martinson W, Eckel SF, Granko RP, Savage S, Crisp B, Smith E, Daniels R, Brennan P, Rich V, Doyle J, May L, Wagner M, Collins B, Lewin G, Ambookan M, Vertichio R, Joseph A, Jackson GF, Maher M, Sabel A, Valdez C, Brown B, Moldenhauer K, Chou J, MacKenzie TD, Lovett PB, Davis-Moon L, Mathew RG, Randolph FT.

Am J Med Qual. 2013 Mar-Apr;28(1 Suppl):3S-28S. doi: 10.1177/1062860612470786. No abstract available.

PMID:
23462139
21.

Endogenous and exogenous pentraxin-3 limits postischemic acute and chronic kidney injury.

Lech M, Römmele C, Gröbmayr R, Eka Susanti H, Kulkarni OP, Wang S, Gröne HJ, Uhl B, Reichel C, Krombach F, Garlanda C, Mantovani A, Anders HJ.

Kidney Int. 2013 Apr;83(4):647-61. doi: 10.1038/ki.2012.463. Epub 2013 Jan 16.

22.

Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1β secretion.

Mulay SR, Kulkarni OP, Rupanagudi KV, Migliorini A, Darisipudi MN, Vilaysane A, Muruve D, Shi Y, Munro F, Liapis H, Anders HJ.

J Clin Invest. 2013 Jan;123(1):236-46. doi: 10.1172/JCI63679. Epub 2012 Dec 10.

23.

Lupus nephritis. How latest insights into its pathogenesis promote novel therapies.

Kulkarni OP, Anders HJ.

Curr Opin Rheumatol. 2012 Sep;24(5):457-65. doi: 10.1097/BOR.0b013e328354c877. Review.

PMID:
22810362
24.

Anti-GBM glomerulonephritis involves IL-1 but is independent of NLRP3/ASC inflammasome-mediated activation of caspase-1.

Lichtnekert J, Kulkarni OP, Mulay SR, Rupanagudi KV, Ryu M, Allam R, Vielhauer V, Muruve D, Lindenmeyer MT, Cohen CD, Anders HJ.

PLoS One. 2011;6(10):e26778. doi: 10.1371/journal.pone.0026778. Epub 2011 Oct 27.

25.

Recombinant chaperonin 10 suppresses cutaneous lupus and lupus nephritis in MRL-(Fas)lpr mice.

Kulkarni OP, Ryu M, Kantner C, Sárdy M, Naylor D, Lambert D, Brown R, Anders HJ.

Nephrol Dial Transplant. 2012 Apr;27(4):1358-67. doi: 10.1093/ndt/gfr544. Epub 2011 Oct 10.

PMID:
21987536
26.

Mdm2 promotes systemic lupus erythematosus and lupus nephritis.

Allam R, Sayyed SG, Kulkarni OP, Lichtnekert J, Anders HJ.

J Am Soc Nephrol. 2011 Nov;22(11):2016-27. doi: 10.1681/ASN.2011010045. Epub 2011 Sep 23.

27.

Interleukin-1 receptor-associated kinase-M suppresses systemic lupus erythematosus.

Lech M, Kantner C, Kulkarni OP, Ryu M, Vlasova E, Heesemann J, Anz D, Endres S, Kobayashi KS, Flavell RA, Martin J, Anders HJ.

Ann Rheum Dis. 2011 Dec;70(12):2207-17. doi: 10.1136/ard.2011.155515. Epub 2011 Aug 29.

PMID:
21875872
28.

Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.

Lichtnekert J, Rupanagudi KV, Kulkarni OP, Darisipudi MN, Allam R, Anders HJ.

J Immunol. 2011 Sep 15;187(6):3413-21. doi: 10.4049/jimmunol.1101125. Epub 2011 Aug 17.

29.

IRF4 deficiency abrogates lupus nephritis despite enhancing systemic cytokine production.

Lech M, Weidenbusch M, Kulkarni OP, Ryu M, Darisipudi MN, Susanti HE, Mittruecker HW, Mak TW, Anders HJ.

J Am Soc Nephrol. 2011 Aug;22(8):1443-52. doi: 10.1681/ASN.2010121260. Epub 2011 Jul 8.

30.

Dual blockade of the homeostatic chemokine CXCL12 and the proinflammatory chemokine CCL2 has additive protective effects on diabetic kidney disease.

Darisipudi MN, Kulkarni OP, Sayyed SG, Ryu M, Migliorini A, Sagrinati C, Parente E, Vater A, Eulberg D, Klussmann S, Romagnani P, Anders HJ.

Am J Pathol. 2011 Jul;179(1):116-24. doi: 10.1016/j.ajpath.2011.03.004. Epub 2011 Apr 30.

31.

Lack of the long pentraxin PTX3 promotes autoimmune lung disease but not glomerulonephritis in murine systemic lupus erythematosus.

Lech M, Römmele C, Kulkarni OP, Susanti HE, Migliorini A, Garlanda C, Mantovani A, Anders HJ.

PLoS One. 2011;6(5):e20118. doi: 10.1371/journal.pone.0020118. Epub 2011 May 27.

32.

An orally active chemokine receptor CCR2 antagonist prevents glomerulosclerosis and renal failure in type 2 diabetes.

Sayyed SG, Ryu M, Kulkarni OP, Schmid H, Lichtnekert J, Grüner S, Green L, Mattei P, Hartmann G, Anders HJ.

Kidney Int. 2011 Jul;80(1):68-78. doi: 10.1038/ki.2011.102. Epub 2011 Apr 20.

33.

GaAs-based surface-normal optical modulator compared to Si and its wavelength response characterization using a supercontinuum laser.

Kulkarni OP, Islam MN, Terry FL Jr.

Opt Express. 2011 Feb 28;19(5):4076-84. doi: 10.1364/OE.19.004076.

PMID:
21369236
34.

Bacterial CpG-DNA accelerates Alport glomerulosclerosis by inducing an M1 macrophage phenotype and tumor necrosis factor-α-mediated podocyte loss.

Ryu M, Kulkarni OP, Radomska E, Miosge N, Gross O, Anders HJ.

Kidney Int. 2011 Jan;79(2):189-98. doi: 10.1038/ki.2010.373. Epub 2010 Oct 20.

35.

4SC-101, a novel small molecule dihydroorotate dehydrogenase inhibitor, suppresses systemic lupus erythematosus in MRL-(Fas)lpr mice.

Kulkarni OP, Sayyed SG, Kantner C, Ryu M, Schnurr M, Sárdy M, Leban J, Jankowsky R, Ammendola A, Doblhofer R, Anders HJ.

Am J Pathol. 2010 Jun;176(6):2840-7. doi: 10.2353/ajpath.2010.091227. Epub 2010 Apr 22.

36.

Lack of SIGIRR/TIR8 aggravates hydrocarbon oil-induced lupus nephritis.

Lech M, Skuginna V, Kulkarni OP, Gong J, Wei T, Stark RW, Garlanda C, Mantovani A, Anders HJ.

J Pathol. 2010 Apr;220(5):596-607. doi: 10.1002/path.2678.

PMID:
20112371
37.

Viral RNA induces type I interferon-dependent cytokine release and cell death in mesangial cells via melanoma-differentiation-associated gene-5: Implications for viral infection-associated glomerulonephritis.

Flür K, Allam R, Zecher D, Kulkarni OP, Lichtnekert J, Schwarz M, Beutler B, Vielhauer V, Anders HJ.

Am J Pathol. 2009 Nov;175(5):2014-22. doi: 10.2353/ajpath.2009.080585. Epub 2009 Oct 22.

38.

Podocytes produce homeostatic chemokine stromal cell-derived factor-1/CXCL12, which contributes to glomerulosclerosis, podocyte loss and albuminuria in a mouse model of type 2 diabetes.

Sayyed SG, Hägele H, Kulkarni OP, Endlich K, Segerer S, Eulberg D, Klussmann S, Anders HJ.

Diabetologia. 2009 Nov;52(11):2445-54. doi: 10.1007/s00125-009-1493-6. Epub 2009 Aug 26.

PMID:
19707743
39.

Bacterial lipopeptide triggers massive albuminuria in murine lupus nephritis by activating Toll-like receptor 2 at the glomerular filtration barrier.

Pawar RD, Castrezana-Lopez L, Allam R, Kulkarni OP, Segerer S, Radomska E, Meyer TN, Schwesinger CM, Akis N, Gröne HJ, Anders HJ.

Immunology. 2009 Sep;128(1 Suppl):e206-21. doi: 10.1111/j.1365-2567.2008.02948.x. Epub 2008 Oct 24.

40.

Trif is not required for immune complex glomerulonephritis: dying cells activate mesangial cells via Tlr2/Myd88 rather than Tlr3/Trif.

Lichtnekert J, Vielhauer V, Zecher D, Kulkarni OP, Clauss S, Segerer S, Hornung V, Mayadas TN, Beutler B, Akira S, Anders HJ.

Am J Physiol Renal Physiol. 2009 Apr;296(4):F867-74. doi: 10.1152/ajprenal.90213.2008. Epub 2009 Jan 21.

41.

Viral 5'-triphosphate RNA and non-CpG DNA aggravate autoimmunity and lupus nephritis via distinct TLR-independent immune responses.

Allam R, Pawar RD, Kulkarni OP, Hornung V, Hartmann G, Segerer S, Akira S, Endres S, Anders HJ.

Eur J Immunol. 2008 Dec;38(12):3487-98. doi: 10.1002/eji.200838604.

42.

Tir8/Sigirr prevents murine lupus by suppressing the immunostimulatory effects of lupus autoantigens.

Lech M, Kulkarni OP, Pfeiffer S, Savarese E, Krug A, Garlanda C, Mantovani A, Anders HJ.

J Exp Med. 2008 Aug 4;205(8):1879-88. doi: 10.1084/jem.20072646. Epub 2008 Jul 21. Erratum in: J Exp Med. 2008 Sep 1;205(9):2179.

43.

Coactivation of Toll-like receptor-3 and -7 in immune complex glomerulonephritis.

Patole PS, Pawar RD, Lichtnekert J, Lech M, Kulkarni OP, Ramanjaneyulu A, Segerer S, Anders HJ.

J Autoimmun. 2007 Aug;29(1):52-9. Epub 2007 Jun 4.

PMID:
17544622
44.

Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus.

Pawar RD, Ramanjaneyulu A, Kulkarni OP, Lech M, Segerer S, Anders HJ.

J Am Soc Nephrol. 2007 Jun;18(6):1721-31. Epub 2007 Apr 25.

45.

Third order cascaded Raman wavelength shifting in chalcogenide fibers and determination of Raman gain coefficient.

Kulkarni OP, Xia C, Lee DJ, Kumar M, Kuditcher A, Islam MN, Terry FL, Freeman MJ, Aitken BG, Currie SC, McCarthy JE, Powley ML, Nolan DA.

Opt Express. 2006 Aug 21;14(17):7924-30.

PMID:
19529161
46.

Mid-infrared supercontinuum generation to 4.5 microm in ZBLAN fluoride fibers by nanosecond diode pumping.

Xia C, Kumar M, Kulkarni OP, Islam MN, Terry FL Jr, Freeman MJ, Poulain M, Mazé G.

Opt Lett. 2006 Sep 1;31(17):2553-5.

PMID:
16902616

Supplemental Content

Loading ...
Support Center